SER has been granted a new patent
Jan 08, 2025, 11:36 PM
-0.43%
What does SER do
Serina Therapeutics, based in Alameda, California, is a clinical-stage biotechnology company developing drug candidates for neurological diseases, focusing on SER-252 for Parkinson's Disease. The company went public on November 29, 2018, and employs four people.
SER filed a patent for "poly(oxazoline) conjugates with pendant cationic groups and lipid nanoparticles including same" on Thu, June 15, 2023.
📡️ Health Care
Patents
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.